เริ่มกันเลย
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

ไม่มีการซื้อขาย
ดูในซูเปอร์ชาร์ต
ภาพรวมการเงินข่าวการสนทนาทางเทคนิคฤดูกาลพันธบัตร

หุ้นกู้ ABBV

ด้านล่างคือรายการของหุ้นกู้ AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 นักลงทุนมักเลือกใช้หุ้นกู้ของบริษัทเพื่อเพิ่มเสถียรภาพในช่วงเวลาที่ตลาดผันผวน ศึกษาราคา อัตราผลตอบแทน และสถิติอื่นๆ และค้นหาการลงทุนที่เชื่อถือได้
สัญลักษณ์
YTM %
ปริมาณการซื้อขาย
ราคา %
ดอกเบี้ย %
วันครบกำหนดอายุ
ยอดคงค้าง
มูลค่าหน้าตั๋ว
จำนวนเงินขั้นต่ำ
ผู้ออก
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7.00%26 K76.04%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6.83%12 K77.91%4.63%2042-10-0167.49 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6.51%202 K82.12%4.85%2044-06-1565.23 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
5.78%091.13%2.63%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5.61%337 K92.25%4.55%2035-03-15107.65 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.51%12.11 M99.79%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.49%26 K90.47%3.20%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.43%7.18 M99.49%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5.41%16.6 M84.34%4.25%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5.41%7.19 M102.70%5.60%2055-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.40%3.59 M92.97%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
5.40%088.17%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
5.39%091.57%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.37%7.5 M92.49%4.75%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.30%204 K100.50%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.29%2.19 M94.73%4.85%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5.24%8.65 M90.47%4.40%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.12%75 K94.39%4.63%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.03%14.99 M90.06%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
4.78%095.98%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
4.72%098.25%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4.68%5.09 M103.90%5.20%2035-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4.68%165 K99.00%4.55%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4.59%2.5 M103.16%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.15%2.4 M103.84%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4.06%388 K103.30%4.88%2030-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
4.04%099.46%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.04%20.65 M96.77%3.20%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
3.99%093.69%2.13%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3.97%1.08 M102.66%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3.95%15.91 M98.83%2.95%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3.94%4 M101.22%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
3.88%2.71 M101.80%4.65%2028-03-151.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3.82%2.46 M101.22%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3.16%0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
3.13%0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3.12%0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
2.99%090.36%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
2.74%097.84%2.13%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.57%0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
2.56%0100.19%2.63%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
2.49%098.91%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
2.32%096.74%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
−5.89%0111.17%2.95%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.